SCHEMBL19976062

SCHEMBL19976062

O=C(Nc1ccc(Cl)c(C(=O)O)c1)c1ccccc1

nearest known ligand 0.73

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.73
RAB9A P51151 5/20 0.73
MAPT P10636 3/20 0.68
SMO Q99835 1/20 0.67
KCNK3 O14649 3/20 0.66
KCNK9 Q9NPC2 3/20 0.66
PPARG P37231 1/20 0.65
PPARA Q07869 1/20 0.65
NR1H4 Q96RI1 1/20 0.65
KMT2A Q03164 3/20 0.65
PKM P14618 1/20 0.65
KDM4E B2RXH2 3/20 0.63
MEN1 O00255 1/20 0.63
LMNA P02545 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
TP53 P04637 1/20 0.59
POLB P06746 2/20 0.58
TDP1 Q9NUW8 2/20 0.58
ACLY P53396 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8278418 0.89 NPC1 (0.71) NPC1RAB9AMAPTSMOKCNK3
SCHEMBL2495198 0.88 KCNK3 (0.67) NPC1RAB9AMAPTKCNK3KCNK9
SCHEMBL23707818 0.86 NR1H4 (0.61) NPC1RAB9AMAPTSMOKCNK3
SCHEMBL2493233 0.86 KCNK3 (0.68) NPC1RAB9AKCNK3KCNK9PPARG
SCHEMBL2494059 0.86 CSF1R (0.67) NPC1RAB9AMAPTKCNK3KCNK9
SCHEMBL11593167 0.85 KMT2A (0.76) NPC1RAB9AMAPTKCNK3KCNK9
SCHEMBL30369807 0.85 NPC1 (1.00) NPC1RAB9AMAPTSMOKCNK3
SCHEMBL4254257 0.85 NPC1 (1.00) NPC1RAB9AMAPTSMOKCNK3
SCHEMBL2498414 0.84 RAB9A (0.76) NPC1RAB9AKCNK3KMT2AMEN1
SCHEMBL2494946 0.84 PPARG (0.62) NPC1RAB9AMAPTPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1051036-A The treatment of HIV (human immunodeficiency virus) infections and in treatment used compound UNIROYAL CHEM CO INC (US) 1991-05-01 CN claimed
US-9926276-B2 Substituted benzamides with activity towards EP4 receptors DRACONIS PHARMA, S.L. (ES) 2018-03-27 US disclosed